Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2015Digestive Diseases

Surrogate Endpoints for Optimal Therapeutic Response to UDCA in Primary Biliary Cholangitis

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHenk R. van BuurenWLWillem J. LammersMHMaren H. Harms

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Buuren et al. (2015) studied this question.

synapsesocial.com/papers/6a19dc41e7f8932c5eeacb36https://doi.org/10.1159/000440759
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biochemical response to ursodeoxycholic acid predicts long‐term outcome in Japanese patients with primary biliary cirrhosis2011 · 55 citations
  2. 2The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary Cirrhosis1983 · 425 citations
  3. 3Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?1999 · 43 citations
  4. 4Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis2005 · 224 citations
  5. 5A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre2010 · 70 citations